Also trades as: KTTAW (NASDAQ) · $vol 0M
KTTA NASDAQ
Pasithea Therapeutics Corp.
1W: -1.1%
1M: -14.9%
3M: -5.0%
YTD: -58.5%
1Y: -35.8%
3Y: -95.1%
$0.48
-0.01 (-2.68%)
Weekly Expected Move ±5.9%
$0
$0
$0
$1
$1
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Smart Money Score
Moderate
50
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap$15.9M
52W Range0.281-2.06
Volume59,809
Avg Volume602,887
Beta0.29
Dividend—
Analyst Ratings
Company Info
CEOTiago Reis Marques
Employees5
SectorHealthcare
IndustryBiotechnology
IPO Date2021-09-15
Websitepasithea.com
1111 Lincoln Road
Miami Beach, FL 33139
US
Miami Beach, FL 33139
US
702 514 4174
About Pasithea Therapeutics Corp.
Pasithea Therapeutics Corp. functions as a biotechnology firm dedicated to the discovery and advancement of novel therapeutic solutions for various psychiatric and neurological conditions. Beyond its research endeavors, the company also plans to establish and manage clinics specializing in depression treatment. These facilities are designed to offer business support, employing trained pharmacists to administer intravenous ketamine infusions. Founded in 2020, the corporation's primary operations are based in Miami Beach, Florida.
Latest News
Pasithea Therapeutics Announces Presentation of Initial PAS-004 Clinical Data from Ongoing Phase 1/1b Clinical Trial in Adult NF1 Patients at the 2026 European Neurofibromatosis Conference
Pasithea Therapeutics Announces Presentation of PAS-004 Data to European Society for Medical Oncology (ESMO) Congress 2026
New Strong Buy Stocks for July 20th
Pasithea Therapeutics Announces Amendments to Clinical Study Protocol for Phase 1/1B NF1 Clinical Trial
Pasithea Therapeutics Announces Exhibit at Children's Tumor Foundation 2026 NF Conference
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Coastlands Capital L | P-Purchase | 100,000 | $0.53 | 2026-06-17 |
| Marques Tiago | A-Award | 1,756,069 | $0.84 | 2026-05-01 |
| STEINMAN LAWRENCE | A-Award | 152,783 | $0.84 | 2026-05-01 |
| Dumesnil Simon | A-Award | 152,783 | $0.84 | 2026-05-01 |
| Schneiderman Daniel | A-Award | 1,129,323 | $0.84 | 2026-05-01 |